Interview by Nicola Miller, RARE Revolution,
featuring Dr Michael Mannstadt, chief of the Endocrine Unit, Massachusetts General Hospital, Boston and principal investigator, CALIBRATE study

“Ten years ago or even five years ago, we would have never thought that this is possible. Now there’s real hope that, thanks to research and advances in science, we can develop treatments that are truly personalised.” Michael

---